Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol [PDF]
Frontiers in Physiology, 2022 BackgroundMany studies have demonstrated the positive clinical value of progestin-primed ovarian stimulation (PPOS) in patients with polycystic ovary syndrome (PCOS) who underwent assisted reproductive technology.
Chen Chen +13 more
doaj +2 more sources
The Comparative Study of Platelet Rich Plasma (PRP) and Plasma Rich in Growth factor (PRGF) in Endometrial Thickness, Implantation Rate and Pregnancy Outcomes in IVF Patients [PDF]
Journal of Pharmacy and Bioallied SciencesBackground: Platelet-rich plasma (PRP) and Plasma Rich in Growth Factors (PRGF) are promising regenerative therapies aimed at enhancing endometrial thickness and improving in vitro fertilization (IVF) outcomes. This study aims to assess the impact of PRP
Mariyam Khan +2 more
doaj +2 more sources
Improving Implantation Rate in 2nd ICSI Cycle through Ovarian Stimulation with FSH and LH in GNRH Antagonist Regimen [PDF]
Revista Brasileira de Ginecologia e Obstetrícia, 2021 Objective To investigate whether patients with a previous recombinant follicle stimulating hormone (rFSH)-stimulated cycle would have improved outcomes with rFSH + recombinant luteinizing hormone (rLH) stimulation in the following cycle.
Amanda Souza Setti +3 more
doaj +2 more sources
Efficacy of In-utero Infusion of Autologous Platelet Rich Plasma Therapy in Women with Recurrent Implantation Failure: A Systematic Review and Meta-analysis of Randomised Controlled Trials [PDF]
Journal of Clinical and Diagnostic Research, 2023 Introduction: In-utero infusion of autologous Platelet Rich Plasma (PRP) is found to be a novel approach to address the thin, non receptive endometrium leading to recurrent implantation failure. Aim: To estimate the efficacy of intrauterine PRP infusion
Soumya Ranjan Panda +4 more
doaj +1 more source
Journal of Human Reproductive Sciences, 2022 Background: Intra-Cytoplasmic Sperm Injection (ICSI) has revolutionized the reproductive outcomes for couples with male factor infertility. Especially in azoospermic men, use of ICSI with surgically retrieved testicular sperm has helped them have their ...
Krishna Chaitanya Mantravadi +2 more
doaj +1 more source
The Predictive Value of Anti-Mullerian Hormone on Pregnancy Rate After IVF [PDF]
Minia Journal of Medical Research, 2020 Introduction: The role of AMH in the ovary is to participate in the regulation of ovarian function, especially in follicle development and selection.
Osama Ibrahim, Hiathm Baha El-Din
doaj +1 more source
Frontiers in Endocrinology, 2020 Growth hormone (GH) has been shown to improve implantation and live birth rates in women of >40 years of age treated by in vitro fertilization (IVF). This effect was initially attributed to a GH effect on oocyte quality, but later studies showed that ...
Jan Tesarik +4 more
doaj +1 more source
Frontiers in Endocrinology, 2023 ObjectiveThe administration of progesterone before transfer in hormone replacement treatment (HRT) is crucial for the clinical outcomes of frozen-thawed embryo transfer (FET), but the optimal duration of progesterone remains controversial.
Ling Liu +5 more
doaj +1 more source
Journal of Human Reproductive Sciences, 2013 Context: Oocyte quality may be a governing factor in influencing in vitro fertilization (IVF) outcomes. However, morphological evaluation of oocyte quality is difficult in conventional IVF cycles.
Bindu N Mehta +4 more
doaj +1 more source
Journal of Human Reproductive Sciences, 2012 Objectives: To evaluate whether three daily doses of GnRH agonist (Inj. Lupride 1 mg SC) administered 6 days after oocyte retrieval increases ongoing pregnancy rates following embryo transfer (ET) in cycles stimulated with the long GnRH agonist protocol.
Dattaprasad B Inamdar, Abha Majumdar
doaj +1 more source